Clinical trials
Completed Communicable Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 1 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 11 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 5 |
| National Center for Research Resources (NCRR) | 5 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Johns Hopkins University | 3 |
| Kaiser Permanente | 3 |
| Washington University School of Medicine | 3 |
| Advanced Life Sciences, Inc. | 2 |
| Christiana Care Health Services | 2 |
| Immorna Biotherapeutics, Inc. | 2 |
| InBios International, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Communicable Diseases | 95 |
| Immune System Diseases | 11 |
| Rare Diseases | 11 |
| COVID-19 | 9 |
| Acquired Immunodeficiency Syndrome | 6 |
| Infections | 6 |
| Arthritis | 4 |
| Connective Tissue Diseases | 4 |
| Hepatitis C | 4 |
| Lupus Erythematosus, Systemic | 4 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.